Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients
Open Access
- 1 December 2012
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 82 (12), 1297-1303
- https://doi.org/10.1038/ki.2012.301
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Beta 2 Microglobulin and the Risk for Cardiovascular Events in Patients With Asymptomatic Carotid AtherosclerosisStroke, 2011
- PROGRESS IN UREMIC TOXIN RESEARCH: Beta2‐MicroglobulinSeminars in Dialysis, 2009
- Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKDAmerican Journal of Kidney Diseases, 2008
- Decrease in Thoracic Vertebral Bone Attenuation With Calcium-Based Phosphate Binders in HemodialysisJournal of Bone and Mineral Research, 2005
- Uremia causes endothelial progenitor cell deficiencyKidney International, 2004
- The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repairKidney International, 2004
- New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up studyAtherosclerosis, 1997
- Assessment of Arterial Distensibility by Automatic Pulse Wave Velocity MeasurementHypertension, 1995
- A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulinBiochemical and Biophysical Research Communications, 1985
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983